Journey Medical (DERM) Other Non-Current Assets (2020 - 2024)
Journey Medical's (DERM) quarterly Other Non-Current Assets came in at $6000.0 in Q3 2024, little changed on a YoY basis from $6000.0 in Q4 2023, and little changed quarter-over-quarter from $6000.0 in Q2 2024.
Analysis
Journey Medical (DERM) Other Non-Current Assets (2020 - 2024) Analysis & Trends
Journey Medical (DERM) has reported Other Non-Current Assets for 5 consecutive years, with $6000.0 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Other Non-Current Assets changed 0.0% year-over-year to $6000.0; the trailing twelve-month figure through Sep 2024 stood at $6000.0 (changed 0.0% YoY), and the FY2023 full-year result was $6000.0, down 93.68% from the prior year.
- Other Non-Current Assets was little changed at $6000.0 in Q3 2024 per DERM's latest filing, from $6000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $8.8 million in Q1 2023 and bottomed at $6000.0 in Q4 2020.
- Historically, Other Non-Current Assets has averaged $726214.3 across 5 years, with a median of $50500.0 in 2020.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 7357.63% in 2023, then tumbled 99.93% in 2024.
- Over 5 years, Other Non-Current Assets stood at $6000.0 in 2020, then soared by 2400.0% to $150000.0 in 2021, then tumbled by 36.67% to $95000.0 in 2022, then sank by 93.68% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $6000.0, $6000.0, and $6000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 5.50 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 42.45 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 86.76 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 239.50 Mn |
| 10 | Journey Medical | 209.23 Mn | 183.58 Mn | 12.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 749,000.00 |
| Dec 31, 2020 | 6,000.00 |